Literature DB >> 27613395

Isolated cardiac sarcoidosis: A focused review of an under-recognized entity.

David R Okada1, Paco E Bravo2, Tomas Vita3, Vikram Agarwal3, Michael T Osborne4, Viviany R Taqueti2, Hicham Skali2, Panithaya Chareonthaitawee5, Sharmila Dorbala2,3, Garrick Stewart2, Marcelo Di Carli2,3, Ron Blankstein6,7.   

Abstract

There is accumulating evidence for the existence of a phenotype of isolated cardiac sarcoidosis (ICS), or sarcoidosis that only involves the heart. In the absence of biopsy-confirmed cardiac sarcoidosis (CS), existing diagnostic criteria require the presence of extra-cardiac sarcoidosis as an inclusion criterion for the diagnosis of CS. Consequently, in the absence of a positive endomyocardial biopsy, ICS is not diagnosable by current guidelines. Therefore, there is uncertainty regarding the epidemiology, pathobiology, clinical characteristics, prognosis, and optimal treatment of ICS. This review will summarize the available data related to the prevalence and prognosis of ICS and will discuss challenges surrounding the diagnosis and management of this under-recognized entity.

Entities:  

Keywords:  Cardiac sarcoidosis; cardiac MRI; cardiac PET

Mesh：

Year:  2016        PMID： 27613395      PMCID： PMC5540795          DOI： 10.1007/s12350-016-0658-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  46 in total

1.  The difficult diagnosis of isolated cardiac sarcoidosis: usefulness of an integrated MRI and PET approach.

Authors:  Giuseppe Galati; Ornella Leone; Claudio Rapezzi
Journal:  Heart       Date:  2013-07-09       Impact factor: 5.994

2.  Isolated cardiac sarcoid in a patient with unexplained syncope.

Authors:  Jason S Chinitz; Lawrence A Inra; Kenneth M Stein; Jonathan W Weinsaft
Journal:  J Cardiovasc Electrophysiol       Date:  2009-10-08

3.  Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography/computed tomography.

Authors:  Theresa Reiter; Rudolf A Werner; Wolfgang R Bauer; Constantin Lapa
Journal:  Eur Heart J       Date:  2015-06-20       Impact factor: 29.983

Review 4.  Myocardial sarcoidosis.

Authors:  O P Sharma; A Maheshwari; K Thaker
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

5.  Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.

Authors:  Shinji Ishimaru; Ichizo Tsujino; Toshiki Takei; Eriko Tsukamoto; Shinji Sakaue; Mitsunori Kamigaki; Naofumi Ito; Hiroshi Ohira; Daisuke Ikeda; Nagara Tamaki; Masaharu Nishimura
Journal:  Eur Heart J       Date:  2005-04-04       Impact factor: 29.983

6.  Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes.

Authors:  Fabio Tavora; Nathaniel Cresswell; Ling Li; Mary Ripple; Carol Solomon; Allen Burke
Journal:  Am J Cardiol       Date:  2009-06-18       Impact factor: 2.778

7.  Cardiac sarcoidosis: recurrent disease in a heart transplant patient following pulmonary tuberculosis infection.

Authors:  Adriana Luk; Andrew Lee; Eric Ahn; Gursharan S Soor; Heather J Ross; Jagdish Butany
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

8.  Right ventricular sarcoidosis: is it time for updated diagnostic criteria?

Authors:  Kairav Vakil; Elina Minami; Daniel P Fishbein
Journal:  Tex Heart Inst J       Date:  2014-04-01

9.  Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Authors:  Ron Blankstein; Michael Osborne; Masanao Naya; Alfonso Waller; Chun K Kim; Venkatesh L Murthy; Pedram Kazemian; Raymond Y Kwong; Michifumi Tokuda; Hicham Skali; Robert Padera; Jon Hainer; William G Stevenson; Sharmila Dorbala; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2013-10-16       Impact factor: 24.094

10.  Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.

Authors:  K J Silverman; G M Hutchins; B H Bulkley
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690
View more
  32 in total

1.  Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis.

Authors:  Paco E Bravo; Amitoj Singh; Marcelo F Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2018-11-02       Impact factor: 5.952

2.  Case Study: Cardiac sarcoidosis resolved with Mycobacterium avium paratuberculosis antibiotics (MAP).

Authors:  Branko G Celler
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 3.  Role of Imaging in Evaluating Infiltrative Heart Disease.

Authors:  Sanjay Divakaran; Avinainder Singh; Bradley Collins; Tomas Vita; Rodney H Falk; Marcelo F Di Carli; Ron Blankstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

Review 4.  Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.

Authors:  Shinichiro Kumita; Keiichiro Yoshinaga; Masao Miyagawa; Mitsuru Momose; Keisuke Kiso; Tokuo Kasai; Masanao Naya
Journal:  J Nucl Cardiol       Date:  2019-08       Impact factor: 5.952

5.  Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

6.  Search for key manifestations to predict inflammation on cardiac PET in suspected cardiac sarcoidosis population.

Authors:  Vasileios Kouranos; Kshama Wechalekar
Journal:  J Nucl Cardiol       Date:  2017-06-27       Impact factor: 5.952

7.  Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.

Authors:  Kalie Y Kebed; Spencer V Carter; Erin Flatley; R Parker Ward; Joshua D Moss; Daniel E Appelbaum; Amita Singh; Roberto M Lang; Roderick Tung; Amit R Patel
Journal:  Int J Cardiovasc Imaging       Date:  2020-11-22       Impact factor: 2.357

8.  A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Patrizio Lancellotti; Fabien Hyafil; Ron Blankstein; Ronald G Schwartz; Wael A Jaber; Raymond Russell; Alessia Gimelli; François Rouzet; Marcus Hacker; Olivier Gheysens; Sven Plein; Edward J Miller; Sharmila Dorbala; Erwan Donal
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

9.  Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Med       Date:  2017-08       Impact factor: 10.057

Review 10.  Echocardiography in Sarcoidosis.

Authors:  Reto Kurmann; Sunil V Mankad; Rekha Mankad
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.